4DMedical Limited (4DX.AX)
AUD 0.25
(0.0%)
AUD 0.25
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 | 4.17 Million AUD | 0.0% |
| 2023 | 4.2 Million AUD | -18.16% |
| 2022 | 5.13 Million AUD | 432.32% |
| 2021 | 965.35 Thousand AUD | 55.41% |
| 2020 | 621.15 Thousand AUD | -58.59% |
| 2019 | 1.5 Million AUD | 0.0% |
| 2018 | - AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q4 | 4.17 Million AUD | 0.0% |
| 2024 Q1 | 3.9 Million AUD | 0.0% |
| 2024 Q2 | 3.9 Million AUD | 0.0% |
| 2024 Q3 | - AUD | -100.0% |
| 2024 FY | 4.17 Million AUD | -0.7% |
| 2023 Q3 | 4.2 Million AUD | -7.66% |
| 2023 FY | 4.2 Million AUD | -18.16% |
| 2023 Q4 | 4.2 Million AUD | 0.0% |
| 2023 Q2 | 4.55 Million AUD | 0.0% |
| 2023 Q1 | 4.55 Million AUD | -11.37% |
| 2022 Q1 | 676.2 Thousand AUD | -29.95% |
| 2022 FY | 5.13 Million AUD | 432.32% |
| 2022 Q4 | 5.13 Million AUD | 0.0% |
| 2022 Q3 | 5.13 Million AUD | 659.94% |
| 2022 Q2 | 676.2 Thousand AUD | 0.0% |
| 2021 FY | 965.35 Thousand AUD | 55.41% |
| 2021 Q2 | 409.96 Thousand AUD | 0.0% |
| 2021 Q1 | 409.96 Thousand AUD | -34.0% |
| 2021 Q3 | 965.35 Thousand AUD | 135.48% |
| 2021 Q4 | 965.35 Thousand AUD | 0.0% |
| 2020 Q4 | 621.15 Thousand AUD | 0.0% |
| 2020 Q1 | 795.58 Thousand AUD | -46.96% |
| 2020 FY | 621.15 Thousand AUD | -58.59% |
| 2020 Q2 | 795.58 Thousand AUD | 0.0% |
| 2020 Q3 | 621.15 Thousand AUD | -21.92% |
| 2019 FY | 1.5 Million AUD | 0.0% |
| 2019 Q4 | 1.5 Million AUD | 0.0% |
| 2019 Q3 | 1.5 Million AUD | 0.0% |
| 2019 Q1 | - AUD | 0.0% |
| 2018 FY | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Adherium Limited | - AUD | -Infinity% |
| Aroa Biosurgery Limited | 5.89 Million AUD | 29.214% |
| Atomo Diagnostics Limited | - AUD | -Infinity% |
| Anteris Technologies Ltd | 1.52 Million AUD | -173.08% |
| Control Bionics Limited | 336.16 Thousand AUD | -1142.252% |
| CardieX Limited | - AUD | -Infinity% |
| Compumedics Limited | - AUD | -Infinity% |
| Cochlear Limited | 202.1 Million AUD | 97.934% |
| CleanSpace Holdings Limited | 2.76 Million AUD | -50.949% |
| Cyclopharm Limited | 4.01 Million AUD | -4.067% |
| EMVision Medical Devices Ltd | 1.76 Million AUD | -136.409% |
| Nova Eye Medical Limited | - AUD | -Infinity% |
| HeraMED Limited | - AUD | -Infinity% |
| Imricor Medical Systems, Inc. | 12.43 Million AUD | 66.423% |
| ImpediMed Limited | 810 Thousand AUD | -415.558% |
| InhaleRx Limited | - AUD | -Infinity% |
| LBT Innovations Limited | 1.74 Million AUD | -139.588% |
| Micro-X Limited | 65 Thousand AUD | -6324.64% |
| Neurotech International Limited | - AUD | -Infinity% |
| OncoSil Medical Limited | - AUD | -Infinity% |
| PolyNovo Limited | 742 Thousand AUD | -462.805% |
| Respiri Limited | - AUD | -Infinity% |
| SomnoMed Limited | 709.07 Thousand AUD | -488.939% |
| Universal Biosensors, Inc. | 3.22 Million AUD | -29.461% |
| Uscom Limited | - AUD | -Infinity% |
| Visioneering Technologies, Inc. | - AUD | -Infinity% |